These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19217286)

  • 21. Discovery of highly potent and selective benzyloxybenzyl-based peroxisome proliferator-activator receptor (PPAR) delta agonists.
    Bratton LD; Filzen GF; Geyer A; Hoffman JK; Lu G; Pulaski J; Trivedi BK; Unangst PC; Xu X
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3624-9. PubMed ID: 17498950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-guided design, synthesis and in vitro evaluation of a series of pyrazole-based fatty acid binding protein (FABP) 3 ligands.
    Beniyama Y; Matsuno K; Miyachi H
    Bioorg Med Chem Lett; 2013 Mar; 23(6):1662-6. PubMed ID: 23395658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Probing the fibrate binding specificity of rat liver fatty acid binding protein.
    Chuang S; Velkov T; Horne J; Wielens J; Chalmers DK; Porter CJ; Scanlon MJ
    J Med Chem; 2009 Sep; 52(17):5344-55. PubMed ID: 19663428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of sulfoximine based inhibitors for HIV-1 protease.
    Raza A; Sham YY; Vince R
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5406-10. PubMed ID: 18829317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding modes of three inhibitors 8CA, F8A and I4A to A-FABP studied based on molecular dynamics simulation.
    Chen J; Wang J; Zhu W
    PLoS One; 2014; 9(6):e99862. PubMed ID: 24918907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biaryl cannabinoid mimetics--synthesis and structure-activity relationship.
    Worm K; Zhou QJ; Stabley GJ; DeHaven RN; Dolle RE
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3652-6. PubMed ID: 17507224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 4-(1H-indazol-5-yl)-6-phenylpyrimidin-2(1H)-one analogs as potent CDC7 inhibitors.
    Shafer CM; Lindvall M; Bellamacina C; Gesner TG; Yabannavar A; Jia W; Lin S; Walter A
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4482-5. PubMed ID: 18672368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyanoguanidine-based lactam derivatives as a novel class of orally bioavailable factor Xa inhibitors.
    Shi Y; Zhang J; Shi M; O'Connor SP; Bisaha SN; Li C; Sitkoff D; Pudzianowski AT; Chong S; Klei HE; Kish K; Yanchunas J; Liu EC; Hartl KS; Seiler SM; Steinbacher TE; Schumacher WA; Atwal KS; Stein PD
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4034-41. PubMed ID: 19541481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NMR structure of a potent small molecule inhibitor bound to human keratinocyte fatty acid-binding protein.
    McDonnell PA; Constantine KL; Goldfarb V; Johnson SR; Sulsky R; Magnin DR; Robl JA; Caulfield TJ; Parker RA; Taylor DS; Adam LP; Metzler WJ; Mueller L; Farmer BT
    J Med Chem; 2006 Aug; 49(16):5013-7. PubMed ID: 16884313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors.
    Xiang Y; Hirth B; Asmussen G; Biemann HP; Bishop KA; Good A; Fitzgerald M; Gladysheva T; Jain A; Jancsics K; Liu J; Metz M; Papoulis A; Skerlj R; Stepp JD; Wei RR
    Bioorg Med Chem Lett; 2011 May; 21(10):3050-6. PubMed ID: 21507633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of potent, selective protein kinase C inhibitors based on a phorbol skeleton.
    Yamatsugu K; Motoki R; Kanai M; Shibasaki M
    Chem Asian J; 2006 Sep; 1(3):314-21. PubMed ID: 17441066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereoselective synthesis and biological evaluation of 3,4-diaminocyclohexanecarboxylic acid derivatives as factor Xa inhibitors.
    Nagata T; Nagamochi M; Kobayashi S; Komoriya S; Yoshino T; Kanno H
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4587-92. PubMed ID: 18675545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold.
    Dodd DS; Sheriff S; Chang CJ; Stetsko DK; Phillips LM; Zhang Y; Launay M; Potin D; Vaccaro W; Poss MA; McKinnon M; Barrish JC; Suchard SJ; Murali Dhar TG
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1908-11. PubMed ID: 17291752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of an N-oxide pyridine GW4064 analog as a potent FXR agonist.
    Feng S; Yang M; Zhang Z; Wang Z; Hong D; Richter H; Benson GM; Bleicher K; Grether U; Martin RE; Plancher JM; Kuhn B; Rudolph MG; Chen L
    Bioorg Med Chem Lett; 2009 May; 19(9):2595-8. PubMed ID: 19328688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and SAR of selective benzothiophene, benzofuran, and indole-based peroxisome proliferator-activated receptor delta agonists.
    Filzen GF; Bratton L; Cheng XM; Erasga N; Geyer A; Lee C; Lu G; Pulaski J; Sorenson RJ; Unangst PC; Trivedi BK; Xu X
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3630-5. PubMed ID: 17512197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urotensin-II receptor antagonists: synthesis and SAR of N-cyclic azaalkyl benzamides.
    Jin J; An M; Sapienza A; Aiyar N; Naselsky D; Sarau HM; Foley JJ; Salyers KL; Knight SD; Keenan RM; Rivero RA; Dhanak D; Douglas SA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3950-4. PubMed ID: 18573659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fused thiophene derivatives as MEK inhibitors.
    Laing VE; Brookings DC; Carbery RJ; Simorte JG; Hutchings MC; Langham BJ; Lowe MA; Allen RA; Fetterman JR; Turner J; Meier C; Kennedy J; Merriman M
    Bioorg Med Chem Lett; 2012 Jan; 22(1):472-5. PubMed ID: 22119475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel high-affinity and selective biaromatic 4-substituted gamma-hydroxybutyric acid (GHB) analogues as GHB ligands: design, synthesis, and binding studies.
    Høg S; Wellendorph P; Nielsen B; Frydenvang K; Dahl IF; Bräuner-Osborne H; Brehm L; Frølund B; Clausen RP
    J Med Chem; 2008 Dec; 51(24):8088-95. PubMed ID: 19053823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of new binding elements in DPP-4 inhibition and their applications in novel DPP-4 inhibitor design.
    Liang GB; Qian X; Biftu T; Singh S; Gao YD; Scapin G; Patel S; Leiting B; Patel R; Wu J; Zhang X; Thornberry NA; Weber AE
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3706-10. PubMed ID: 18524582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of brain penetrant, soluble, pyrazole amide EP1 receptor antagonists.
    Hall A; Billinton A; Bristow AK; Brown SH; Chowdhury A; Cutler L; Giblin GM; Goldsmith P; Hayhow TG; Kilford IR; Naylor A; Passingham B; Rawlings DA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4027-32. PubMed ID: 18571922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.